Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
Coronavirus disease 2019 (COVID-19) is a fatal infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The virus infection is initiated upon recognition and binding of the spike (S) protein receptor-binding domain (RBD) to the host cell surface receptor, angiotensi...
Saved in:
Main Authors: | Arun Bahadur Gurung (Author), Mohammad Ajmal Ali (Author), Joongku Lee (Author), Mohammad Abul Farah (Author), Khalid Mashay Al-Anazi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
by: Xi Chen, et al.
Published: (2022) -
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
by: Paolo Coghi, et al.
Published: (2021) -
Withanone from Withania somnifera Attenuates SARS-CoV-2 RBD and Host ACE2 Interactions to Rescue Spike Protein Induced Pathologies in Humanized Zebrafish Model
by: Balkrishna A, et al.
Published: (2021) -
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction
by: Sara M. Villada-Troncoso, et al.
Published: (2024) -
Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes
by: Ceren Guney, et al.
Published: (2021)